A citation-based method for searching scientific literature

Werner Poewe, Klaus Seppi, Caroline M Tanner, Glenda M Halliday, Patrik Brundin, Jens Volkmann, Anette-Eleonore Schrag, Anthony E Lang. Nat Rev Dis Primers 2017
Times Cited: 1745







List of co-cited articles
489 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


MDS clinical diagnostic criteria for Parkinson's disease.
Ronald B Postuma, Daniela Berg, Matthew Stern, Werner Poewe, C Warren Olanow, Wolfgang Oertel, José Obeso, Kenneth Marek, Irene Litvan, Anthony E Lang,[...]. Mov Disord 2015
13

Epidemiology of Parkinson's disease.
Lonneke M L de Lau, Monique M B Breteler. Lancet Neurol 2006
11

Parkinson's disease.
Lorraine V Kalia, Anthony E Lang. Lancet 2015
8

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.
Christopher G Goetz, Barbara C Tilley, Stephanie R Shaftman, Glenn T Stebbins, Stanley Fahn, Pablo Martinez-Martin, Werner Poewe, Cristina Sampaio, Matthew B Stern, Richard Dodel,[...]. Mov Disord 2008
7

Parkinsonism: onset, progression and mortality.
M M Hoehn, M D Yahr. Neurology 1967
6

Staging of brain pathology related to sporadic Parkinson's disease.
Heiko Braak, Kelly Del Tredici, Udo Rüb, Rob A I de Vos, Ernst N H Jansen Steur, Eva Braak. Neurobiol Aging 2003
6

Diagnosis and Treatment of Parkinson Disease: A Review.
Melissa J Armstrong, Michael S Okun. JAMA 2020
573
6

Epidemiology of Parkinson's disease.
Ole-Bjørn Tysnes, Anette Storstein. J Neural Transm (Vienna) 2017
869
6

Alpha-synuclein in Lewy bodies.
M G Spillantini, M L Schmidt, V M Lee, J Q Trojanowski, R Jakes, M Goedert. Nature 1997
5

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.
J A Obeso, M Stamelou, C G Goetz, W Poewe, A E Lang, D Weintraub, D Burn, G M Halliday, E Bezard, S Przedborski,[...]. Mov Disord 2017
364
5

Genetics of Parkinson's disease.
Christine Klein, Ana Westenberger. Cold Spring Harb Perspect Med 2012
687
5


Alzheimer disease.
David S Knopman, Helene Amieva, Ronald C Petersen, Gäel Chételat, David M Holtzman, Bradley T Hyman, Ralph A Nixon, David T Jones. Nat Rev Dis Primers 2021
189
5

Mitochondrial Dysfunction and Mitophagy in Parkinson's Disease: From Mechanism to Therapy.
Ana Belen Malpartida, Matthew Williamson, Derek P Narendra, Richard Wade-Martins, Brent J Ryan. Trends Biochem Sci 2021
94
5

The Emerging Evidence of the Parkinson Pandemic.
E Ray Dorsey, Todd Sherer, Michael S Okun, Bastiaan R Bloem. J Parkinsons Dis 2018
325
5

Parkinson's disease.
Bastiaan R Bloem, Michael S Okun, Christine Klein. Lancet 2021
307
5

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.
A J Hughes, S E Daniel, L Kilford, A J Lees. J Neurol Neurosurg Psychiatry 1992
4


Systematic review of levodopa dose equivalency reporting in Parkinson's disease.
Claire L Tomlinson, Rebecca Stowe, Smitaa Patel, Caroline Rick, Richard Gray, Carl E Clarke. Mov Disord 2010
4

Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson's disease.
Seung Pil Yun, Tae-In Kam, Nikhil Panicker, SangMin Kim, Yumin Oh, Jong-Sung Park, Seung-Hwan Kwon, Yong Joo Park, Senthilkumar S Karuppagounder, Hyejin Park,[...]. Nat Med 2018
444
4

MDS research criteria for prodromal Parkinson's disease.
Daniela Berg, Ronald B Postuma, Charles H Adler, Bastiaan R Bloem, Piu Chan, Bruno Dubois, Thomas Gasser, Christopher G Goetz, Glenda Halliday, Lawrence Joseph,[...]. Mov Disord 2015
668
4

Update of the MDS research criteria for prodromal Parkinson's disease.
Sebastian Heinzel, Daniela Berg, Thomas Gasser, Honglei Chen, Chun Yao, Ronald B Postuma. Mov Disord 2019
222
4

Genetics of Parkinson's disease: An introspection of its journey towards precision medicine.
Sara Bandres-Ciga, Monica Diez-Fairen, Jonggeol Jeff Kim, Andrew B Singleton. Neurobiol Dis 2020
126
4

The prevalence of Parkinson's disease: a systematic review and meta-analysis.
Tamara Pringsheim, Nathalie Jette, Alexandra Frolkis, Thomas D L Steeves. Mov Disord 2014
4

Imprecise vowel articulation as a potential early marker of Parkinson's disease: effect of speaking task.
Jan Rusz, Roman Cmejla, Tereza Tykalova, Hana Ruzickova, Jiri Klempir, Veronika Majerova, Jana Picmausova, Jan Roth, Evzen Ruzicka. J Acoust Soc Am 2013
71
5

Parkinson's disease: clinical features and diagnosis.
J Jankovic. J Neurol Neurosurg Psychiatry 2008
4

Parkinson disease.
R Balestrino, A H V Schapira. Eur J Neurol 2020
298
4

LRRK2 in Parkinson disease: challenges of clinical trials.
Eduardo Tolosa, Miquel Vila, Christine Klein, Olivier Rascol. Nat Rev Neurol 2020
166
4

Non-motor features of Parkinson disease.
Anthony H V Schapira, K Ray Chaudhuri, Peter Jenner. Nat Rev Neurosci 2017
648
4

Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030.
E R Dorsey, R Constantinescu, J P Thompson, K M Biglan, R G Holloway, K Kieburtz, F J Marshall, B M Ravina, G Schifitto, A Siderowf,[...]. Neurology 2007
4

Skin α-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Parkinson Disease.
Zerui Wang, Katelyn Becker, Vincenzo Donadio, Sandra Siedlak, Jue Yuan, Masih Rezaee, Alex Incensi, Anastasia Kuzkina, Christina D Orrú, Curtis Tatsuoka,[...]. JAMA Neurol 2020
74
5

Blinded RT-QuIC Analysis of α-Synuclein Biomarker in Skin Tissue From Parkinson's Disease Patients.
Sireesha Manne, Naveen Kondru, Huajun Jin, Geidy E Serrano, Vellareddy Anantharam, Arthi Kanthasamy, Charles H Adler, Thomas G Beach, Anumantha G Kanthasamy. Mov Disord 2020
49
8

The role of oxidative stress in Parkinson's disease.
Vera Dias, Eunsung Junn, M Maral Mouradian. J Parkinsons Dis 2013
883
4

PINK1 is selectively stabilized on impaired mitochondria to activate Parkin.
Derek P Narendra, Seok Min Jin, Atsushi Tanaka, Der-Fen Suen, Clement A Gautier, Jie Shen, Mark R Cookson, Richard J Youle. PLoS Biol 2010
4

Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy.
Ana Maria Cuervo, Leonidas Stefanis, Ross Fredenburg, Peter T Lansbury, David Sulzer. Science 2004
4

Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities.
Sarah J Tabrizi, Michael D Flower, Christopher A Ross, Edward J Wild. Nat Rev Neurol 2020
105
4

The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis.
Lauren Hirsch, Nathalie Jette, Alexandra Frolkis, Thomas Steeves, Tamara Pringsheim. Neuroepidemiology 2016
280
3


Protein transmission in neurodegenerative disease.
Chao Peng, John Q Trojanowski, Virginia M-Y Lee. Nat Rev Neurol 2020
162
3

Microglial exosomes facilitate α-synuclein transmission in Parkinson's disease.
Min Guo, Jian Wang, Yanxin Zhao, Yiwei Feng, Sida Han, Qiang Dong, Mei Cui, Kim Tieu. Brain 2020
122
3


Recent Advances in Biomarkers for Parkinson's Disease.
Runcheng He, Xinxiang Yan, Jifeng Guo, Qian Xu, Beisha Tang, Qiying Sun. Front Aging Neurosci 2018
69
4

Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders.
Thomas G Beach, Charles H Adler, Lucia I Sue, Linda Vedders, Lihfen Lue, Charles L White Iii, Haru Akiyama, John N Caviness, Holly A Shill, Marwan N Sabbagh,[...]. Acta Neuropathol 2010
586
3

Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies.
Mike A Nalls, Cornelis Blauwendraat, Costanza L Vallerga, Karl Heilbron, Sara Bandres-Ciga, Diana Chang, Manuela Tan, Demis A Kia, Alastair J Noyce, Angli Xue,[...]. Lancet Neurol 2019
625
3

The genetic architecture of Parkinson's disease.
Cornelis Blauwendraat, Mike A Nalls, Andrew B Singleton. Lancet Neurol 2020
293
3

A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci.
Diana Chang, Mike A Nalls, Ingileif B Hallgrímsdóttir, Julie Hunkapiller, Marcel van der Brug, Fang Cai, Geoffrey A Kerchner, Gai Ayalon, Baris Bingol, Morgan Sheng,[...]. Nat Genet 2017
594
3

Meta-analysis of brain iron levels of Parkinson's disease patients determined by postmortem and MRI measurements.
Jian-Yong Wang, Qing-Qing Zhuang, Lan-Bing Zhu, Hui Zhu, Ting Li, Rui Li, Song-Fang Chen, Chen-Ping Huang, Xiong Zhang, Jian-Hong Zhu. Sci Rep 2016
106
3

Parkinson's Disease and the Environment.
Nicole Ball, Wei-Peng Teo, Shaneel Chandra, James Chapman. Front Neurol 2019
136
3

α-Synuclein in Parkinson's disease.
Leonidas Stefanis. Cold Spring Harb Perspect Med 2012
633
3

Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology.
David K Simon, Caroline M Tanner, Patrik Brundin. Clin Geriatr Med 2020
176
3


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.